Next Article in Journal
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019
Next Article in Special Issue
Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study
Previous Article in Journal
Cytotoxic Activity of α-Aminophosphonic Derivatives Coming from the Tandem Kabachnik–Fields Reaction and Acylation
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(4), 507; https://doi.org/10.3390/ph16040507
Action Date Notes Link
article xml file uploaded 29 March 2023 12:57 CEST Original file -
article xml uploaded. 29 March 2023 12:57 CEST Update https://www.mdpi.com/1424-8247/16/4/507/xml
article pdf uploaded. 29 March 2023 12:57 CEST Version of Record https://www.mdpi.com/1424-8247/16/4/507/pdf
article supplementary file uploaded. 29 March 2023 12:57 CEST - https://www.mdpi.com/1424-8247/16/4/507#supplementary
article html file updated 29 March 2023 12:58 CEST Original file -
article html file updated 6 April 2023 23:31 CEST Update https://www.mdpi.com/1424-8247/16/4/507/html
Back to TopTop